COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?

COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?

Bibliographic Details
Main Authors:	Nicole F. Clark, Andrew W. Taylor-Robinson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Medicine
Subjects:	chlorophyll therapy lymphopenia SARS-CoV-2 COVID-19 coronavirus
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.620175/full

Similar Items

COVID-19 Therapy: Could a Chlorophyll Derivative Promote Cellular Accumulation of Zn2+ Ions to Inhibit SARS-CoV-2 RNA Synthesis?
by: Nicole F. Clark, et al.
Published: (2020-08-01)

Lymphopenia and Early Variation of Lymphocytes to Predict In-Hospital Mortality and Severity in ED Patients with SARS-CoV-2 Infection
by: Maxence Simon, et al.
Published: (2022-03-01)

Conceptual framework for SARS-CoV-2–related lymphopenia
by: Ilnaz Rahimmanesh, et al.
Published: (2022-01-01)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
by: Ting-Ting Sheu, et al.
Published: (2021-04-01)

Worsening of Lymphopenia during Apremilast Treatment
by: Antonios G.A. Kolios, et al.
Published: (2016-11-01)

Is Lymphopenia a Predictor of Mortality in Patients with COVID-19?
by: Jehat Kılıc, et al.
Published: (2023-01-01)

Pre-Existing Lymphopenia Increases the Risk of Hospitalization and Death after SARS-CoV-2 Infection
by: Riccardo Garbo, et al.
Published: (2022-01-01)

Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs
by: Daphne S. Bakker, et al.
Published: (2018-10-01)

Possible Mechanisms of Lymphopenia in Severe Tuberculosis
by: Fei Li, et al.
Published: (2023-10-01)

Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
by: Zijing Guo, et al.
Published: (2021-09-01)

Is Lymphopenia Detected in Sarcoidosis Associated with the Disease Activity?
by: Coşkun Doğan, et al.
Published: (2019-07-01)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
by: Saba Ebrahimi, BSc, et al.
Published: (2021-04-01)

Lymphopenia: A predictive marker of disease severity in COVID-19 infection
by: Georgeta Daniela Georgescu, et al.
Published: (2021-12-01)

Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
by: María Martínez-Urbistondo, et al.
Published: (2021-08-01)

Lymphopenia in Esophageal Cancer: What Have We Learned?
by: Jia-Lin Wang, et al.
Published: (2021-03-01)

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
by: Giuseppe Carlo Iorio, et al.
Published: (2020-11-01)

Recalcitrant warts and lymphopenia in a young male
by: Shaikah Al-Aojan, MBBS, et al.
Published: (2021-07-01)

Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets
by: Gavin Giovannoni, et al.
Published: (2021-12-01)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
by: Francesca Cottini, et al.
Published: (2021-02-01)

Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches
by: Thao-Nguyen Pham, et al.
Published: (2023-02-01)

High prevalence of infections in non-COVID-19 patients admitted to the Emergency Department with severe lymphopenia
by: Arthur Baïsse, et al.
Published: (2022-03-01)

Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate
by: Dipen Sangurdekar, et al.
Published: (2019-11-01)

CMV Infection and Lymphopenia: Warning Markers of Pneumocystis Pneumonia in Kidney Transplant Recipients
by: Isabelle Eberl, et al.
Published: (2024-01-01)

Association of Lymphopenia with Short Term Outcomes of Sepsis Patients; a Brief Report
by: Hojat Sheikh Motahar Vahedi, et al.
Published: (2019-01-01)

Lymphopenia and lymphocytosis in practical healthy people born and living in the North
by: Veronika P. Patrakeeva, et al.
Published: (2020-09-01)

Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?
by: Nicole F. Clark, et al.
Published: (2022-07-01)

Electroacupuncture at ST36 (Zusanli) Prevents T-Cell Lymphopenia and Improves Survival in Septic Mice
by: Lv ZY, et al.
Published: (2022-05-01)

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
by: Qianwen Zhao, et al.
Published: (2020-07-01)

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
by: Guillaume Eberst, et al.
Published: (2022-05-01)

Effect of Lymphopenia on Tumor Response and Clinical Outcomes Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer
by: Deck J, et al.
Published: (2023-05-01)

Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea
by: Stefan Hatzl, et al.
Published: (2023-05-01)

Association of lymphopenia and eosinophilia with dimethylfumarate treatment efficacy and tolerability in psoriasis: a retrospective study
by: D.F.C van Hezik, et al.
Published: (2020-05-01)

T-Cell Lymphopenia Detected by Newborn Screening in Two Siblings with an Xq13.1 Duplication
by: Xavier Rios, et al.
Published: (2017-07-01)

Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer
by: Fang Chen, et al.
Published: (2022-07-01)

Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
by: Stephen Ahn, et al.
Published: (2023-03-01)

Prognostic Value and Risk Factors of Treatment-Related Lymphopenia in Malignant Glioma Patients Treated With Chemoradiotherapy: A Systematic Review and Meta-Analysis
by: Yongchao Zhang, et al.
Published: (2022-01-01)

The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy
by: Liu M, et al.
Published: (2021-03-01)

Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation
by: Enrique Alfaro, et al.
Published: (2022-03-01)

Neoadjuvant chemoradiotherapy induced lymphopenia in gastric cancer and associations with spleen dosimetry and survival outcomes
by: Ji-jin Wang, et al.
Published: (2023-05-01)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
by: Wang Jing, MD, et al.
Published: (2022-09-01)